$BNR Income Statement | Understand Stock

$BNR

$11.87 +$0.72 (6.46%) Close

$BNR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Comprehensive Loss

In millions of CNY; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Service
Product
Total revenues
Cost of revenues:
Service
Product
Total cost of revenues:
Gross Profit
Operating expenses:
Research and development expenses
Selling and marketing expenses
General and administrative expenses
Impairment loss on long-lived assets
Total operating expenses
Loss from operations
Interest income
Interest expense
Interest expenses
Other income (loss), net
Foreign exchange loss, net
Change in fair value of warrant liability
Loss before income tax
Income tax expenses
Net loss
Common Class A
Common Class B
Total net loss
Net loss attributable to Burning Rock Biotech Limited
Accretion of convertible preferred shares
Loss per share for class A and class B ordinary shares:
Ordinary shares—basic and diluted
Common Class A
Common Class B
Total ordinary shares—basic and diluted
Loss per share - basic
Loss per share - diluted

Weighted average shares outstanding used in loss per share computation:
Ordinary shares—basic and diluted
Common Class A
Common Class B
Total ordinary shares—basic and diluted
Weighted average shares outstanding used in loss per share - basic
Common Class A
Common Class B
Weighted-average number of ordinary shares outstanding – diluted
Common Class A
Common Class B

Other comprehensive income (loss), net of tax of nil:
Foreign currency translation adjustments
Total comprehensive loss
Total comprehensive loss attributable to Burning Rock Biotech Limited

Comments